financial estimates
HTG Molecular Preliminary Q1 Revenues Fall 56 Percent
For the three months ended March 31, the firm said that preliminary revenues for Q1 are expected to be $1.4 million compared with $3.2 million a year ago.
360Dx Index Declines 2 Percent in March, Continuing Downward Slope
Of the 31 companies in the index, 11 firms saw their stock prices increase, while 20 saw their share prices decline.
Exagen Q4 2020 Revenues Up 24 Percent, Full Year Revenues Grow 4 Percent
The company's fourth quarter revenues rose to $12.7 million, while full year revenues rose to $42 million.
LabCorp Q4 Revenues Rise 52 Percent
Revenues were $4.49 billion, up from $2.95 billion in the same quarter last year and beating analysts' average estimate of $3.95 billion.
Meridian Bioscience Fiscal Q1 Revenues Rise 96 Percent
The firm's life science revenues increased nearly fivefold, while diagnostics revenues declined 13 percent year over year.
Mar 2, 2020
Oxford Immunotec Q4 Revenues Grow 18 Percent
Feb 26, 2020
Natera Q4 Revenues Rise 24 Percent
Feb 20, 2020
Curetis Preliminary 2019 Revenues Up 64 Percent
Jan 30, 2020
Danaher Q4 Revenues Climb 6 Percent
Jan 13, 2020
CareDx Preliminary Q4 Revenues up 53 Percent
Jan 12, 2020
NanoString Preliminary Q4 Revenues Grow 22 Percent
Aug 6, 2019
Invitae Q2 Revenues Increase 43 Percent
May 28, 2019